報價延遲最少15分鐘:2025/05/15 03:29 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.07 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.32/-0.99
|
|
企業價值
92.47M
|
| 資產負債 |
|
每股賬面淨值
1.95
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
16.15M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/15 03:29 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. |